Table 6 Depicts an in vitro time-kill kinetics study that compares the growth of Staphylococcus aureus, Escherichia coli, and Candida albicans treated with 210 µg/ml ZnO/MnO nanocomposite to untreated controls and measures viable counts (log10CFU/ml ± SD) as well as reductive percentage (% ± SD).

From: Large-scale production of myco-fabricated ZnO/MnO nanocomposite using endophytic Colonstachys rosea with its antimicrobial efficacy against human pathogens

Cultivation period (hr)

Pathogens treated with 210 µg/ml of ZnO/MnO nanocomposite

Staphylococcus aureus

Escherichia coli

Candida albicans

Viable counts (log10CFU/ml ± SD)

Growth reduction (% ± SD)

Viable counts (log10CFU/ml ± SD)

Growth reduction (% ± SD)

Viable counts (log10CFU/ml ± SD)

Biomass reduction (% ± SD)

Control

Treated

Control

Treated

Control

Treated

0

0.36 ± 0.04

0.32 ± 0.07

 

0.3 ± 0.23

0.25 ± 0.04

 

0.41 ± 0.09

0.35 ± 0.09

 

6

1.98 ± 0.48

0.65 ± 0.47

52.02 ± 4.26

1.06 ± 0.78

0.59 ± 0.54

44.34 ± 5.45

1.48 ± 0.12

0.94 ± 1.24

36.32 ± 1.39

12

2.76 ± 0.98

0.95 ± 0.74

80.07 ± 3.12

3.21 ± 1.23

1.09 ± 0.04

66.04 ± 4.12

1.98 ± 0.07

0.96 ± 0.09

51.53 ± 2.98

18

4.14 ± 1.36

1.13 ± 0.95

86.62 ± 6.45

4.56 ± 1.60

1.3 ± 0.68

71.49 ± 3.12

2.51 ± 1.13

1.09 ± 1.87

56.60 ± 3.89

24

4.89 ± 1.45

1.48 ± 0.71

94.27 ± 2.59

4.98 ± 0.35

1.21 ± 0.85

75.70 ± 2.36

3.44 ± 0.78

1.26 ± 0.19

63.33 ± 2.12

30

5.35 ± 2.15

1.54 ± 0.93

95.51 ± 2.84

5.25 ± 1.24

1.19 ± 0.78

77.33 ± 2.75

4.39 ± 1.36

1.15 ± 0.57

73.793 ± 1.09

36

5.73 ± 1.97

1.28 ± 1.07

96.86 ± 5.23

5.5 ± 1.40

1.01 ± 0.74

81.64 ± 3.12

5.29 ± 0.97

1.18 ± 0.16

77.71 ± 3.89

Back to article page